1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hepatobiliary Disease Global Clinical Trials Review, H1, 2015

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Hepatobiliary Disease Global Clinical Trials Review, H1, 2015" provides data on the Hepatobiliary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatobiliary Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatobiliary Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hepatobiliary Disease 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Hepatobiliary Disease 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Pfizer Inc. 24
Clinical Trial Overview of Pfizer Inc. 24
Clinical Trial Overview of Top Institutes / Government 25
Hiroshima University Hospital 25
Clinical Trial Overview of Hiroshima University Hospital 25
Hokkaido University Hospital 26
Clinical Trial Overview of Hokkaido University Hospital 26
Osaka University 27
Clinical Trial Overview of Osaka University 27
The University of Tokyo 28
Clinical Trial Overview of The University of Tokyo 28
Chiba University 29
Clinical Trial Overview of Chiba University 29
Guangdong Science and Technology Department 30
Clinical Trial Overview of Guangdong Science and Technology Department 30
Haydarpasa Numune State Hospital 31
Clinical Trial Overview of Haydarpasa Numune State Hospital 31
Hokkaido University School of Medicine 32
Clinical Trial Overview of Hokkaido University School of Medicine 32
Japanese Endoscopist and IVRists group for Biliary Tract Cancer 33
Clinical Trial Overview of Japanese Endoscopist and IVRists group for Biliary Tract Cancer 33
Kyoto Prefectural University of Medicine 34
Clinical Trial Overview of Kyoto Prefectural University of Medicine 34
Five Key Clinical Profiles 35
Appendix 49
Abbreviations 49
Definitions 49
Research Methodology 50
Secondary Research 50
About GlobalData 51
Contact Us 51
Disclaimer 51
Source 51

List of Tables
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region, 2015* 6
Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10
Hepatobiliary Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12
Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 15
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Hepatobiliary Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 19
Hepatobiliary Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 19
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20
Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 21
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 24
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015* 25
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University Hospital, 2015* 26
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* 27
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 28
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015* 29
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Science and Technology Department, 2015* 30
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Haydarpasa Numune State Hospital, 2015* 31
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2015* 32
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Endoscopist and IVRists group for Biliary Tract Cancer, 2015* 33
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 34

List of Figures
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 10
Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12
Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 15
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20
Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 21
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
GlobalData Methodology 50

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.